Skip to main content

Table 1 Characteristics of HF according to gender

From: Clinical characteristics and in-hospital outcome of heart failure in women: a single center registry from Egyptian cardiac care unit

  Male, n = 178 Female, n = 118 P value
HFrEF 113 (63.5%) 73 (61.9%) 0.579
Age 59.9 ± 9 65.3 ± 11 0.0001
BMI 29.84 ± 3.2 31.63 ± 4 0.01
Obesity 81 (54.5%) 80 (67.8%) 0.000
DM 74 (41.6%) 45(38.1%) 0.628
HTN 109 (61.2%) 67(56.8%) 0.470
Dyslipidemia 59 (33.1%) 47(39.8%) 0.266
Smoking 120 (67%) 2 (1.7%) 0.000
Previous MI 52 (29.6%) 19 (16.1%) 0.019
Previous PCI 34 (19.1%) 12 (10.2%) 0.043
Prior CABG 18 (10.1%) 8 (6.78%) 0.226
Valve surgery 8 (4.5%) 6 (5.1%) 0.339
Addiction 13 (7.3%) 0 (0%) 0.001
STEMI 22 (12.4%) 16 (14%) 0.329
UA/NSTEMI 16 (9%) 21 (8.5%) 0.878
Cardiogenic shock 39 (22%) 25 (21.2%) 0.351
CHB 3 (1.7%) 1 (0.8%) 0.296
AF/Flutter 16 (8.9%) 25 (21.2%) 0.041
IE 1 (0.6%) 1 (0.8%) 0.916
PE 1 (0.6%) 3 (2.5%) 0.148
Aortic dissection 1 (0.6%) 3 (2.5%) 0.148
Cardiomyopathies 18 (10.1%) 23 (19.5%) 0.011
Chest pain (CP) 35 (19.7%) 25 (21.2%) 0.199
Orthopnea 118 (66%) 80 (67.8%) 0.195
PND 40 (22.5%) 16 (13.6%) 0.040
Palpitations 18 (10.1%) 14 (11.9%) 0.191
Syncope 10 (5.62%) 1 (0.85%) 0.024
Cough 55 (30.9%) 38 (32.2%) 0.704
Edema 63 (35.4%) 38 (32.2%) 0.847
Pacemaker 5 (2.8%) 2 (1.7%) 0.320
ICD 0 (0%) 1 (0.85%) 0.163
Killip class    
 I 33 (18.5%) 11 (5.9%) 0.023
 II 8 (4.5%) 6 (5.1%) 0.211
 III 32 (18%) 27(22.8%) 0.119
 IV 102 (57%) 71 (60.2%) 0.176
Pricardiocentesis 3 (1.7%) 1 (0.85%) 0.541
Thazides 22 (12.4%) 8 (6.8%) 0.119
Loop diuretics 109 (61%) 68(57.6%) 0.535
Nitrates 103 (58%) 67 (56.8%) 0.853
Warfarin 63 (35.4%) 31 (26.3%) 0.099
Clopedogril 75 (42.1%) 58 (49.2%) 0.235
Aldesterone antagonist 88 (49.4%) 50 (42.4%) 0.233
Digixon 67 (37.6%) 32 (27.1%) 0.060
Duration of stay 8.71 ± 7 7.06 ± 5 0.020
Mortality 19 (10.7%) 13(11.1%) 0.740
HFpEF 65 (36.5%) 45(38.1%) 0.524
Sepsis 1 (0.6%) 3(2.5%) 0.254
Pneumonia 5 (2.81%) 6 (5.1%) 0.204
AKI 23 (13%) 12 (10.2%) 0.336
CKD/ESRD 7 (4%) 3 (2.5%) 0.291
Resp. failure 0(0%) 4(3.4%) 0.016
liver failure 1(0.6%) 9(7.6%) 0.000
Tamponade 1 (0.6%) 3 (2.5%) 0.254
GIT bleeding 1 (0.6%) 3 (2.5%) 0.148
CCI 167 (93%) 112 (94%) 0.692
Previous MI 54 (30.3%) 17 (14.4%) 0.003
Previous CHF 85 (47.8%) 42 (35.6%) 0.054
PVD 5 (2.8%) 2 (1.7%) 0.296
CVA/TIA 9 (5.1%) 10 (8.5%) 0.167
Hemiplegia 1 (0.6%) 2 (1.7%) 0.220
COPD 15 (8.4%) 10 (8.5%) 0.351
VHD 14 (7.8%) 18(15.2%) 0.020
Peptic ulcer 0 (0%) 1(0.85%) 0.163
Cancer 0 (0%) 1 (0.85%) 0.163
Depression 1 (0.6%) 2 (1.7%) 0.220
Dementia 6 (3.4%) 3 (2.5%) 0.328
Metastasis 1 (0.6%) 3 (2.5%) 0.148
Endotracheal intubation 27 (15.2%) 15 (13%) 0.553
HIV 1 (0.6%) 1 (0.85%) 0.336
Cellulitis 1 (0.6%) 9 (7.6%) 0.000
PCI 20 (11.2%) 7 (6%) 0.021
CRT 3 (1.68%) 2 (1.69%) 0.329
Mechanical ventilation 28 (15.7%) 15 (22%) 0.471
CVP 121 (68%) 71 (60%) 0.168
CA 4 (2.25%) 5 (4.24%) 0.329
DC shock 8 (4.5%) 1 (0.85%) 0.044
Coma 1 (0.6%) 0 (0%) 0.437
Fever 1 (0.6%) 1 (0.85%)
Hemoptysis 0 (0.6%) 1 (0.85%)
Lanoxin toxicisty 0 (0%) 1 (0.85%)
Mechanical ventilation 28 (15.7%) 15(21.7%) 0.471
Amiodarone 17 (9.6%) 7 (14.4%) 0.200
UFH 62(34.8%) 34(28.8%) 0.279
LMWH 100(56.2%) 79 (67%) 0.064
Lytic therapy 45 (25.3%) 32(27.1%) 0.724
ACEI/ARBS 112(62.9%) 78(66.1%) 0.741
Warfarin 22 (12.4%) 22(18.6%) 0.137
Beta-blockers 61 (34.3%) 45 (38%) 0.794
Survivors 159 (89%) 105 (88%) 0.750
  1. BMI body mass index, DM diabetes mellitus, HTN hypertension, STEMI ST segment elevation myocardial infarction, UA unstable angina, IE infective endocarditis, PE pulmonary embolism, PND paroxysmal nocturnal dyspnea, CHB complete heart block, Af atrial flutter, AF atrial fibrillation, CCI Charlson comorbidity index, PCI percutaneous coronary intervention, CA coronary angiography, CVA cerebrovascular accident